Commercial AI solutions in detecting COVID-19 pneumonia in chest CT: not yet ready for clinical implementation?

ABSTRACT:

Objectives

In response to the COVID-19 pandemic, many researchers have developed artificial intelligence (AI) tools to differentiate COVID-19 pneumonia from other conditions in chest CT. However, in many cases, performance has not been clinically validated. The aim of this study was to evaluate the performance of commercial AI solutions in differentiating COVID-19 pneumonia from other lung conditions.

Methods

Four commercial AI solutions were evaluated on a dual-center clinical dataset consisting of 500 CT studies; COVID-19 pneumonia was microbiologically proven in 50 of these. Sensitivity, specificity, positive and negative predictive values, and AUC were calculated. In a subgroup analysis, the performance of the AI solutions in differentiating COVID-19 pneumonia from other

SUBMITTER: Jungmann F 

PROVIDER: S-EPMC8700707 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature